Hanmi

News

Lilly licenses Hanmi GLP-2 drug in $1.26bn deal

Eli Lilly's relentless pipeline-building drive has continued with a licensing deal for Hanmi's sonefpeglutide, in phase 2 for short bowel syndrome.

News

Lilly axes trial of Hanmi's arthritis drug

Lilly may decide to develop drug in other indications

Digital

South Korea flag is waving at a beautiful and peaceful sky in day time while sun is shining. 3D Rendering

South Korea hopes big data will boost life sciences industry

South Korea is to build a comprehensive database of genetic and biometric data from 10 million people, in a bid to boost its pharma and biotech industry.

News

Genentech and Hanmi strike $900m cancer deal

Roche unit partners with South Korean firm.

Views & Analysis

Digital Health Round-up – NHS & DeepMind, funding for Apreci...

A round-up of this week’s top digital healthcare news. Marco Ricci reports.

Lilly licenses Hanmi GLP-2 drug in $1.26bn deal

Lilly axes trial of Hanmi's arthritis drug

South Korea hopes big data will boost life sciences industry

Genentech and Hanmi strike $900m cancer deal

Digital Health Round-up – NHS & DeepMind, funding for Apreci...

FDA clears Viridian's Tepezza rival for thyroid eye disease

Discover a new era of healthcare panel engagement: Grounded ...

Hanmi

Editor's Picks